The wide-ranging pact involves as many as 13 drugs and marks the latest example of the growing relationship between Chinese pharmaceutical firms and their U.S. and Europe-based counterparts.
Nội dung đang được cập nhật.
Pharmaceutical intelligence Việt Nam · Cập nhật theo tuần
The wide-ranging pact involves as many as 13 drugs and marks the latest example of the growing relationship between Chinese pharmaceutical firms and their U.S. and Europe-based counterparts.
Nội dung đang được cập nhật.